Oncolytic viruses as platform for multimodal cancer therapeutics: a promising land
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncolytic viruses as platform for multimodal cancer therapeutics: a promising land
Authors
Keywords
-
Journal
CANCER GENE THERAPY
Volume 21, Issue 7, Pages 261-263
Publisher
Springer Nature
Online
2014-07-18
DOI
10.1038/cgt.2014.31
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Complementary Induction of Immunogenic Cell Death by Oncolytic Parvovirus H-1PV and Gemcitabine in Pancreatic Cancer
- (2014) A. L. Angelova et al. JOURNAL OF VIROLOGY
- Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo
- (2014) Mingzhe Weng et al. Molecular Cancer
- Smac mimetics and innate immune stimuli synergize to promote tumor death
- (2014) Shawn T Beug et al. NATURE BIOTECHNOLOGY
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
- (2014) D. Zamarin et al. Science Translational Medicine
- Oncolytic Viruses and Their Application to Cancer Immunotherapy
- (2014) E. A. Chiocca et al. Cancer Immunology Research
- Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity
- (2014) Zong Sheng Guo et al. Frontiers in Oncology
- Oncolytic viruses as therapeutic cancer vaccines
- (2013) David L Bartlett et al. Molecular Cancer
- T-cell Engager-armed Oncolytic Vaccinia Virus Significantly Enhances Antitumor Therapy
- (2013) Feng Yu et al. MOLECULAR THERAPY
- Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in V600D/EBRAF mutant melanoma depends on JNK and TNF-α signaling
- (2013) J N Kyula et al. ONCOGENE
- Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases
- (2013) M. Gil et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mounting a strategic offense: fighting tumor vasculature with oncolytic viruses
- (2013) Fernando A. Angarita et al. TRENDS IN MOLECULAR MEDICINE
- Combining Oncolytic HSV-1 with Immunogenic Cell Death-Inducing Drug Mitoxantrone Breaks Cancer Immune Tolerance and Improves Therapeutic Efficacy
- (2013) S. T. Workenhe et al. Cancer Immunology Research
- A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
- (2012) Abhishek D Garg et al. EMBO JOURNAL
- Photodynamic therapy augments the efficacy of oncolytic vaccinia virus against primary and metastatic tumours in mice
- (2011) M Gil et al. BRITISH JOURNAL OF CANCER
- A Novel Oncolytic Herpes Simplex Virus that Synergizes with Phosphoinositide 3-kinase/Akt Pathway Inhibitors to Target Glioblastoma Stem Cells
- (2011) R. Kanai et al. CLINICAL CANCER RESEARCH
- Oncolytic Virus-Mediated Manipulation of DNA Damage Responses: Synergy With Chemotherapy in Killing Glioblastoma Stem Cells
- (2011) Ryuichi Kanai et al. JNCI-Journal of the National Cancer Institute
- Chemokine Expression From Oncolytic Vaccinia Virus Enhances Vaccine Therapies of Cancer
- (2011) Jun Li et al. MOLECULAR THERAPY
- Intelligent Design: Combination Therapy With Oncolytic Viruses
- (2009) Kathryn Ottolino-Perry et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started